Tech Company Financing Transactions
Nuvaira Funding Round
On 2/12/2019, Nuvaira landed $79 million in investment from U.S. Venture Partners, Advanced Technology Ventures and Endeavour Vision.
Transaction Overview
Company Name
Announced On
2/12/2019
Transaction Type
Venture Equity
Amount
$79,000,000
Round
Undisclosed
Investors
Proceeds Purpose
These funds will be used to support the pivotal AIRFLOW-3 clinical trial for FDA approval, and to implement a targeted clinical development strategy in key European markets.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3750 Annapolis Ln. North 105
Minneapolis, MN 55447
USA
Minneapolis, MN 55447
USA
Phone
Website
Email Address
Overview
Nuvaira, Inc. is a privately held medical device company that develops minimally invasive products to make breathing easier for patients suffering from obstructive lung diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Wahr
Chief Financial Officer
Thomas Griffin
Vice President
James Pavliska
VP - Bus. Development
Lisa Rogan
VP - Operations
David Kressler
VP - Regulatory Affairs
Karen Peterson
Browse more venture capital transactions:
Prev: 2/12/2019: RapidDeploy venture capital transaction
Next: 2/12/2019: SendFriend venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs